BAC
Bank of America Corporation
BAC has the edge over PROV overall, supported by stronger valuation and stronger fundamentals.
PROV
Provident Financial Holdings, Inc.
PROV has slightly lower modeled downside risk, despite its lower overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
PROV Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
PROV's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like PROV.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over PROV in the historical PE scenario, which offers more potential upside but is not a forecast.
PROV PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $11.99 | -34% |
| Forward | 13x | $18.24 | — |
| Fair | 15x | $15.03 | -18% |
| Expensive | 18x | $18.75 | +2.8% |
| Current | 18x | $18.24 | — |
Historical ranges are pointers, not guarantees.
PROV's PE is in its expensive range at 18x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over PROV on the outlook, with more favorable revenue expectations.
PROV Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect PROV's earnings to grow and its profitability to improve, with its revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over PROV on earnings, with more consistent year-over-year improvement.
PROV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.35 | +32% |
| Q3 2026 | $1.03 | +14% |
| Q2 2026 | $1.03 | +11% |
| Q1 2026 | $0.92 | -5.2% |
| Q4 2025 | $0.99 | +8.8% |
| Q3 2025 | $0.90 | -17% |
| Q2 2025 | $0.93 | -12% |
| Q1 2025 | $0.97 | -4.9% |
| Q4 2024 | $0.91 | -19% |
PROV earned $1.03 per share over the past year, up 14% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over PROV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over PROV on profitability, with a higher operating margin.
PROV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $10.6M | +8.5% |
| Q2 2026 | $10.6M | +8.5% |
| Q1 2026 | $9.9M | -2.4% |
| Q4 2025 | $9.8M | +2.5% |
| Q3 2025 | $9.7M | +2.4% |
| Q2 2025 | $9.8M | -1.6% |
| Q1 2025 | $10.1M | +7.6% |
| Q4 2024 | $9.6M | -0.5% |
PROV's revenue has picked up after three years of holding roughly level: $11M last quarter, up 8.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | -7.5 points |
| Q2 2026 | 28% | +4.1 points |
| Q1 2026 | 19% | -6.9 points |
| Q4 2025 | 21% | +8.1 points |
| Q3 2025 | 28% | -0.2 points |
| Q2 2025 | 24% | -4.2 points |
| Q1 2025 | 26% | +3.8 points |
| Q4 2024 | 13% | -19 points |
PROV's operating margin was 21% last quarter, down 7.5 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
PROV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3M | +74% |
| Q2 2026 | $3.3M | +53% |
| Q1 2026 | $1.7M | -47% |
| Q4 2025 | $1M | +236% |
| Q3 2025 | $2.5M | +2.7% |
| Q2 2025 | $2.2M | +$3M |
| Q1 2025 | $3.3M | +27% |
| Q4 2024 | $307K | +$749K |
PROV has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over PROV on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
PROV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.9% | -189K shares |
| 1 year | -5% | -332K shares |
| 3 years | -10% | -733K shares |
| 5 years | -17% | -1.3M shares |
| Available history | -18% | -1.4M shares |
PROV has 6M diluted shares, down 5% from a year ago, with $7M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.7M |
| Q2 2026 | $1.9M |
| Q1 2026 | $1.5M |
| Q4 2025 | $1.5M |
| Q3 2025 | $1.1M |
| Q2 2025 | $1.2M |
| Q1 2025 | $801,000 |
| Q4 2024 | $1M |
PROV spent $7M buying back its own shares over the past year, up 64% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
PROV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.1x | Net Cash |
| Q2 2026 | -3.6x | Net Cash |
| Q1 2026 | -4.4x | Net Cash |
| Q4 2025 | -4.1x | Net Cash |
| Q3 2025 | -4.0x | Net Cash |
| Q2 2025 | -4.3x | Net Cash |
| Q1 2025 | -4.0x | Net Cash |
| Q4 2024 | -3.7x | Net Cash |
PROV has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
PROV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.0 | Neutral |
| Stochastic | 45.7 | Neutral |
PROV's weekly RSI is 64 (neutral) and its Stochastic is 46 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over PROV on valuation relative to its sector.
PROV PE vs Financial Services Sector
| Metric | PROV | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 13x | 36% above |
| PE % | 79 | 63 | 16 pts above |
PROV is trading at 18x earnings, a 36% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
PROV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.2 | 0% above |
| 20 week MA | $18.0 | 1.1% above |
| 50 week MA | $17.1 | 6.7% above |
| 100 week MA | $16.2 | 12% above |
| 200 week MA | $14.9 | 23% above |
PROV has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
PROV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.0 | $15.8 | -28% |
| 2021 | $15.8 | $16.7 | +5.7% |
| 2022 | $16.7 | $13.8 | -17% |
| 2023 | $13.8 | $12.6 | -8.4% |
| 2024 | $12.6 | $15.9 | +26% |
| 2025 | $15.9 | $16.1 | +1.1% |
| 2026 YTD | $16.1 | $18.2 | +13% |
PROV has the edge over BAC on returns for 2026, with the stronger performance.